L-type calcium channel blockade alleviates molecular and reversal spatial learning and memory alterations induced by entorhinal amyloid pathology in rats

Behavioural Brain Research

Volumn 237, Issue 1, 2013, Pages 190-199

  Gholamipour Badie, Hamid ^a   Naderi, Nima ^a   Khodagholi, Fariba ^a   Shaerzadeh, Fatemeh ^a   Motamedi, Fereshteh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Beta amyloid; Calcium channel blockers; Entorhinal cortex; Spatial learning and memory

Indexed keywords

CALCIUM CHANNEL L TYPE; CALPAIN 2; CASPASE 12; CASPASE 3; ISRADIPINE; NIMODIPINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENTORHINAL CORTEX; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; MAZE TEST; MENTAL TASK; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; REFERENCE MEMORY; SPATIAL MEMORY;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; AREA UNDER CURVE; CALCIUM CHANNEL BLOCKERS; CALPAIN; CASPASES; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; IN SITU NICK-END LABELING; ISRADIPINE; LEARNING DISORDERS; MALE; MAZE LEARNING; MEMORY DISORDERS; NIMODIPINE; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; REVERSAL LEARNING; TIME FACTORS;

EID: 84867411898     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.09.045     Document Type: Article

References (73)

1. Katzman R., Saitoh T. Advances in Alzheimer's disease. FASEB Journal 1991, 5:278-286.
2. Bondi M.W., Salmon D.P., Monsch A.U., Galasko D., Butters N., Klauber M.R., et al. Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology 1995, 45:2203-2206.
3. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 1996, 16:921-932.
4. Kar S., Slowikowski S.P., Westaway D., Mount H.T. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. Journal of Psychiatry and Neuroscience 2004, 29:427-441.
5. Nagele R.G., Wegiel J., Venkataraman V., Imaki H., Wang K.C. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiology of Aging 2004, 25:663-674.
6. Tran M.H., Yamada K., Nabeshima T. Amyloid beta-peptide induces cholinergic dysfunction and cognitive deficits: a minireview. Peptides 2002, 23:1271-1283.
7. Eichenbaum H., Lipton P.A. Towards a functional organization of the medial temporal lobe memory system: role of the parahippocampal and medial entorhinal cortical areas. Hippocampus 2008, 18:1314-1324.
8. Squire L.R., Stark C.E.L., Clark R.E. The medial temporal lobe. Annual Review of Neuroscience 2004, 27:279-306.
9. Gomez-Isla T., Price J.L., McKeel D.W., Morris J.C., Growdon J.H., Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. Journal of Neuroscience 1996, 16:4491-4500.
10. Masdeu J.C., Zubieta J.L., Arbizu J. Neuroimaging as a marker of the onset and progression of Alzheimer's disease. Journal of the Neurological Sciences 2005, 236:55-64.
11. Wu W., Small S.A. Imaging the earliest stages of Alzheimer's disease. Current Alzheimer Research 2006, 3:529-539.
12. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica 1991, 82:239-259.
13. Gabuzda D., Busciglio J., Chen L.B., Matsudaira P., Yankner B.A. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. Journal of Biological Chemistry 1994, 269:13623-13628.
14. Rovira C., Arbez N., Mariani J. Abeta(25-35) and Abeta(1-40) act on different calcium channels in CA1 hippocampal neurons. Biochemical and Biophysical Research Communications 2002, 296:1317-1321.
15. MacManus A., Ramsden M., Murray M., Henderson Z., Pearson H.A., Campbell V.A. Enhancement of Ca(2+) influx and voltage-dependent Ca(2+) channel activity by beta-amyloid (1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1beta. Journal of Biological Chemistry 2000, 275:4713-4718.
16. Whitson J.S., Appel S.H. Neurotoxicity of A beta amyloid protein in vitro is not altered by calcium channel blockade. Neurobiology of Aging 1995, 16:5-10.
17. Mattson M.P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R.E. beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. Journal of Neuroscience 1992, 12:376-389.
18. Guo Q., Sopher B.L., Furukawa K., Pham D.G., Robinson N., Martin G.M., et al. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: involvement of calcium and oxyradicals. Journal of Neuroscience 1997, 17:4212-4222.
19. Begley J.G., Duan W., Chan S., Duff K., Mattson M.P. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. Journal of Neurochemistry 1999, 72:1030-1039.
20. Mattson M.P., Chan S.L. Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. Journal of Molecular Neuroscience 2001, 17:205-224.
21. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. Journal of Biological Chemistry 2005, 280:17294-17300.
22. 2+] in adult Alzheimer's disease mice. Journal of Neurochemistry 2008, 105:262-271.
23. Weiner M.F. Alzheimer's disease: diagnosis and treatment. Harvard Review of Psychiatry 1997, 4:306-316.
24. Inzitari D., Poggesi A. Calcium channel blockers and stroke. Aging Clinical and Experimental Research 2005, 17:16-30.
25. Pasternak B., Svanstrom H., Nielsen N.M., Fugger L., Melbye M., Hviid A. Use of calcium channel blockers and Parkinson's disease. American Journal of Epidemiology 2012, 175:627-635.
26. Baumann O., Walz B. Endoplasmic reticulum of animal cells and its organization into structural and functional domains. International Review of Cytology 2001, 205:149-214.
27. Kaufman R.J. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes and Development 1999, 13:1211-1233.
28. Paschen W. Dependence of vital cell function on endoplasmic reticulum calcium levels: implications for the mechanisms underlying neuronal cell injury in different pathological states. Cell Calcium 2001, 29:1-11.
29. Nakagawa T., Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. Journal of Cell Biology 2000, 150:887-894.
30. Mattson M.P., Partin J., Begley J.G. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. Brain Research 1998, 807:167-176.
31. Gervais F.G., Xu D., Robertson G.S., Vaillancourt J.P., Zhu Y., Huang J., et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999, 97:395-406.
32. Forette F., Seux M.L., Staessen J.A., Thijs L., Birkenhäger W.H., Babarskiene M.R., et al. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. The Lancet 1998, 352:1347-1351.
33. Fritze J., Walden J. Clinical findings with nimodipine in dementia: test of the calcium hypothesis. Journal of Neural Transmission Supplementum 1995, 46:439-453.
34. Tollefson G.D. Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia. Biological Psychiatry 1990, 27:1133-1142.
35. Lopez-Arrieta J.M., Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database of Systematic Reviews 2002, CD000147.
36. Anekonda T.S., Quinn J.F., Harris C., Frahler K., Wadsworth T.L., Woltjer R.L. L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer's disease. Neurobiology of Disease 2011, 41:62-70.
37. Sipos E., Kurunczi A., Kasza A., Horváth J., Felszeghy K., Laroche S., et al. [beta]-Amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease. Neuroscience 2007, 147:28-36.
38. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier/Academic press.
39. Davoodi F.G., Motamedi F., Naghdi N., Akbari E. Effect of reversible inactivation of the reuniens nucleus on spatial learning and memory in rats using Morris water maze task. Behavioural Brain Research 2009, 198:130-135.
40. Akbari E., Naghdi N., Motamedi F. The selective orexin 1 receptor antagonist SB-334867-A impairs acquisition and consolidation but not retrieval of spatial memory in Morris water maze. Peptides 2007, 28:650-656.
41. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72:248-254.
42. Takuma K., Yan S.S., Stern D.M., Yamada K. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease. Journal of Pharmacological Sciences 2005, 97:312-316.
43. Perrin B.J., Huttenlocher A. Calpain. International Journal of Biochemistry and Cell Biology 2002, 34:722-725.
44. Ramin M., Azizi P., Motamedi F., Haghparast A., Khodagholi F. Inhibition of JNK phosphorylation reverses memory deficit induced by beta-amyloid (1-42) associated with decrease of apoptotic factors. Behavioural Brain Research 2011, 217:424-431.
45. Awasthi A., Matsunaga Y., Yamada T. Amyloid-beta causes apoptosis of neuronal cells via caspase cascade, which can be prevented by amyloid-beta-derived short peptides. Experimental Neurology 2005, 196:282-289.
46. Xiong M., Zhang T., Zhang L.M., Lu S.D., Huang Y.L., Sun F.Y. Caspase inhibition attenuates accumulation of beta-amyloid by reducing beta-secretase production and activity in rat brains after stroke. Neurobiology of Disease 2008, 32:433-441.
47. Otto T., Schottler F., Staubli U., Eichenbaum H., Lynch G. Hippocampus and olfactory discrimination learning: effects of entorhinal cortex lesions on olfactory learning and memory in a successive-cue, go-no-go task. Behavioral Neuroscience 1991, 105:111.
48. Parron C., Save E. Evidence for entorhinal and parietal cortices involvement in path integration in the rat. Experimental Brain Research 2004, 159:349-359.
49. Galani R., Weiss I., Cassel J.C., Kelche C. Spatial memory, habituation, and reactions to spatial and nonspatial changes in rats with selective lesions of the hippocampus, the entorhinal cortex or the subiculum. Behavioural Brain Research 1998, 96:1-12.
50. Levisohn L., Isacson O. Excitotoxic lesions of the rat entorhinal cortex. Effects of selective neuronal damage on acquisition and retention of a non-spatial reference memory task. Brain Research 1991, 564:230-244.
51. Spowart-Manning L., van der Staay F. Spatial discrimination deficits by excitotoxic lesions in the Morris water escape task. Behavioural Brain Research 2005, 156:269-276.
52. Harris J.A., Devidze N., Verret L., Ho K., Halabisky B., Thwin M.T., et al. Transsynaptic progression of amyloid-beta-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron 2010, 68:428-441.
53. Eijkenboom M., Blokland A., van der Staay F.J. Modelling cognitive dysfunctions with bilateral injections of ibotenic acid into the rat entorhinal cortex. Neuroscience 2000, 101:27-39.
54. Kopniczky Z., Dochnal R., Macsai M., Pal A., Kiss G., Mihaly A., et al. Alterations of behavior and spatial learning after unilateral entorhinal ablation of rats. Life Sciences 2006, 78:2683-2688.
55. Parron C., Save E. Comparison of the effects of entorhinal and retrosplenial cortical lesions on habituation, reaction to spatial and non-spatial changes during object exploration in the rat. Neurobiology of Learning and Memory 2004, 82:1-11.
56. Spowart-Manning L., van der Staay F.J. Spatial discrimination deficits by excitotoxic lesions in the Morris water escape task. Behavioural Brain Research 2005, 156:269-276.
57. Aggleton J.P., Vann S.D., Oswald C.J., Good M. Identifying cortical inputs to the rat hippocampus that subserve allocentric spatial processes: a simple problem with a complex answer. Hippocampus 2000, 10:466-474.
58. Garthe A., Behr J., Kempermann G. Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. PLoS ONE 2009, 4:e5464.
59. Donovan M.H., Yazdani U., Norris R.D., Games D., German D.C., Eisch A.J. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. Journal of Comparative Neurology 2006, 495:70-83.
60. Lopez-Toledano M.A., Shelanski M.L. Increased neurogenesis in young transgenic mice overexpressing human APP(Sw, Ind). Journal of Alzheimers Disease 2007, 12:229-240.
61. Sun B., Halabisky B., Zhou Y., Palop J.J., Yu G., Mucke L., et al. Imbalance between GABAergic and glutamatergic transmission impairs adult neurogenesis in an animal model of alzheimer's disease. Cell Stem Cell 2009, 5:624-633.
62. Kim H.S., Park C.H., Cha S.H., Lee J.H., Lee S., Kim Y., et al. Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. FASEB Journal 2000, 14:1508-1517.
63. Copani A., Bruno V., Battaglia G., Leanza G., Pellitteri R., Russo A., et al. Activation of metabotropic glutamate receptors protects cultured neurons against apoptosis induced by beta-amyloid peptide. Molecular Pharmacology 1995, 47:890-897.
64. 2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation. Journal of Neurobiology 1995, 26:325-338.
65. 2+ channels: a possible involvement of free radicals. Journal of Neurochemistry 1997, 68:265-271.
66. Ekinci F.J., Malik K.U., Shea T.B. Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration. Journal of Biological Chemistry 1999, 274:30322-30327.
67. Xie C.-W. Calcium-regulated signaling pathways. Neuromolecular Medicine 2004, 6.
68. Freir D.B., Costello D.A., Herron C.E. A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. Journal of Neurophysiology 2003, 89:3061-3069.
69. Facchinetti F., Fasolato C., Del Giudice E., Burgo A., Furegato S., Fusco M., et al. Nimodipine selectively stimulates beta-amyloid 1-42 secretion by a mechanism independent of calcium influx blockage. Neurobiology of Aging 2006, 27:218-227.
70. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000, 403:98-103.
71. Saito K., Elce J.S., Hamos J.E., Nixon R.A. Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:2628-2632.
72. Tan Y., Dourdin N., Wu C., De Veyra T., Elce J.S., Greer P.A. Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. Journal of Biological Chemistry 2006, 281:16016-16024.
73. Hitomi J., Katayama T., Taniguchi M., Honda A., Imaizumi K., Tohyama M. Apoptosis induced by endoplasmic reticulum stress depends on activation of caspase-3 via caspase-12. Neuroscience Letters 2004, 357:127-130.